CYP27A1 loss dysregulates cholesterol homeostasis in prostate cancer

Mahmoud A. Alfaqih, Erik R. Nelson, Wen Liu, Rachid Safi, Jeffery S. Jasper, Everardo Macias, Joseph Geradts, J. Will Thompson, Laura G. Dubois, Michael R. Freeman, Ching Yi Chang, Jen Tsan Chi, Donald P. McDonnell, Stephen J. Freedland

Research output: Contribution to journalArticle

Abstract

In this study, we used a bioinformatic approach to identify genes whose expression is dysregulated in human prostate cancers. One of the most dramatically downregulated genes identified encodes CYP27A1, an enzyme involved in regulating cellular cholesterol homeostasis. Importantly, lower CYP27A1 transcript levels were associated with shorter disease-free survival and higher tumor grade. Loss of CYP27A1 in prostate cancer was confirmed at the protein level by immunostaining for CYP27A1 in annotated tissue microarrays. Restoration of CYP27A1 expression in cells where its gene was silenced attenuated their growth in vitro and in tumor xenografts. Studies performed in vitro revealed that treatment of prostate cancer cells with 27-hydroxycholesterol (27HC), an enzymatic product of CYP27A1, reduced cellular cholesterol content in prostate cancer cell lines by inhibiting the activation of sterol regulatory-element binding protein 2 and downregulating low-density lipoprotein receptor expression. Our findings suggest that CYP27A1 is a critical cellular cholesterol sensor in prostate cells and that dysregulation of the CYP27A1/27HC axis contributes significantly to prostate cancer pathogenesis.

Original languageEnglish (US)
Pages (from-to)1662-1673
Number of pages12
JournalCancer Research
Volume77
Issue number7
DOIs
StatePublished - Jan 1 2017

Fingerprint

Prostatic Neoplasms
Homeostasis
Cholesterol
Sterol Regulatory Element Binding Protein 2
Down-Regulation
LDL Receptors
Computational Biology
Heterografts
Genes
Disease-Free Survival
Prostate
Neoplasms
Gene Expression
Cell Line
Enzymes
Growth
Proteins
27-hydroxycholesterol
In Vitro Techniques

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Alfaqih, M. A., Nelson, E. R., Liu, W., Safi, R., Jasper, J. S., Macias, E., ... Freedland, S. J. (2017). CYP27A1 loss dysregulates cholesterol homeostasis in prostate cancer. Cancer Research, 77(7), 1662-1673. https://doi.org/10.1158/0008-5472.CAN-16-2738

CYP27A1 loss dysregulates cholesterol homeostasis in prostate cancer. / Alfaqih, Mahmoud A.; Nelson, Erik R.; Liu, Wen; Safi, Rachid; Jasper, Jeffery S.; Macias, Everardo; Geradts, Joseph; Thompson, J. Will; Dubois, Laura G.; Freeman, Michael R.; Chang, Ching Yi; Chi, Jen Tsan; McDonnell, Donald P.; Freedland, Stephen J.

In: Cancer Research, Vol. 77, No. 7, 01.01.2017, p. 1662-1673.

Research output: Contribution to journalArticle

Alfaqih, MA, Nelson, ER, Liu, W, Safi, R, Jasper, JS, Macias, E, Geradts, J, Thompson, JW, Dubois, LG, Freeman, MR, Chang, CY, Chi, JT, McDonnell, DP & Freedland, SJ 2017, 'CYP27A1 loss dysregulates cholesterol homeostasis in prostate cancer', Cancer Research, vol. 77, no. 7, pp. 1662-1673. https://doi.org/10.1158/0008-5472.CAN-16-2738
Alfaqih, Mahmoud A. ; Nelson, Erik R. ; Liu, Wen ; Safi, Rachid ; Jasper, Jeffery S. ; Macias, Everardo ; Geradts, Joseph ; Thompson, J. Will ; Dubois, Laura G. ; Freeman, Michael R. ; Chang, Ching Yi ; Chi, Jen Tsan ; McDonnell, Donald P. ; Freedland, Stephen J. / CYP27A1 loss dysregulates cholesterol homeostasis in prostate cancer. In: Cancer Research. 2017 ; Vol. 77, No. 7. pp. 1662-1673.
@article{e7b989fcd4014104a91f83c9a5bc3eca,
title = "CYP27A1 loss dysregulates cholesterol homeostasis in prostate cancer",
abstract = "In this study, we used a bioinformatic approach to identify genes whose expression is dysregulated in human prostate cancers. One of the most dramatically downregulated genes identified encodes CYP27A1, an enzyme involved in regulating cellular cholesterol homeostasis. Importantly, lower CYP27A1 transcript levels were associated with shorter disease-free survival and higher tumor grade. Loss of CYP27A1 in prostate cancer was confirmed at the protein level by immunostaining for CYP27A1 in annotated tissue microarrays. Restoration of CYP27A1 expression in cells where its gene was silenced attenuated their growth in vitro and in tumor xenografts. Studies performed in vitro revealed that treatment of prostate cancer cells with 27-hydroxycholesterol (27HC), an enzymatic product of CYP27A1, reduced cellular cholesterol content in prostate cancer cell lines by inhibiting the activation of sterol regulatory-element binding protein 2 and downregulating low-density lipoprotein receptor expression. Our findings suggest that CYP27A1 is a critical cellular cholesterol sensor in prostate cells and that dysregulation of the CYP27A1/27HC axis contributes significantly to prostate cancer pathogenesis.",
author = "Alfaqih, {Mahmoud A.} and Nelson, {Erik R.} and Wen Liu and Rachid Safi and Jasper, {Jeffery S.} and Everardo Macias and Joseph Geradts and Thompson, {J. Will} and Dubois, {Laura G.} and Freeman, {Michael R.} and Chang, {Ching Yi} and Chi, {Jen Tsan} and McDonnell, {Donald P.} and Freedland, {Stephen J.}",
year = "2017",
month = "1",
day = "1",
doi = "10.1158/0008-5472.CAN-16-2738",
language = "English (US)",
volume = "77",
pages = "1662--1673",
journal = "Cancer Research",
issn = "0008-5472",
publisher = "American Association for Cancer Research Inc.",
number = "7",

}

TY - JOUR

T1 - CYP27A1 loss dysregulates cholesterol homeostasis in prostate cancer

AU - Alfaqih, Mahmoud A.

AU - Nelson, Erik R.

AU - Liu, Wen

AU - Safi, Rachid

AU - Jasper, Jeffery S.

AU - Macias, Everardo

AU - Geradts, Joseph

AU - Thompson, J. Will

AU - Dubois, Laura G.

AU - Freeman, Michael R.

AU - Chang, Ching Yi

AU - Chi, Jen Tsan

AU - McDonnell, Donald P.

AU - Freedland, Stephen J.

PY - 2017/1/1

Y1 - 2017/1/1

N2 - In this study, we used a bioinformatic approach to identify genes whose expression is dysregulated in human prostate cancers. One of the most dramatically downregulated genes identified encodes CYP27A1, an enzyme involved in regulating cellular cholesterol homeostasis. Importantly, lower CYP27A1 transcript levels were associated with shorter disease-free survival and higher tumor grade. Loss of CYP27A1 in prostate cancer was confirmed at the protein level by immunostaining for CYP27A1 in annotated tissue microarrays. Restoration of CYP27A1 expression in cells where its gene was silenced attenuated their growth in vitro and in tumor xenografts. Studies performed in vitro revealed that treatment of prostate cancer cells with 27-hydroxycholesterol (27HC), an enzymatic product of CYP27A1, reduced cellular cholesterol content in prostate cancer cell lines by inhibiting the activation of sterol regulatory-element binding protein 2 and downregulating low-density lipoprotein receptor expression. Our findings suggest that CYP27A1 is a critical cellular cholesterol sensor in prostate cells and that dysregulation of the CYP27A1/27HC axis contributes significantly to prostate cancer pathogenesis.

AB - In this study, we used a bioinformatic approach to identify genes whose expression is dysregulated in human prostate cancers. One of the most dramatically downregulated genes identified encodes CYP27A1, an enzyme involved in regulating cellular cholesterol homeostasis. Importantly, lower CYP27A1 transcript levels were associated with shorter disease-free survival and higher tumor grade. Loss of CYP27A1 in prostate cancer was confirmed at the protein level by immunostaining for CYP27A1 in annotated tissue microarrays. Restoration of CYP27A1 expression in cells where its gene was silenced attenuated their growth in vitro and in tumor xenografts. Studies performed in vitro revealed that treatment of prostate cancer cells with 27-hydroxycholesterol (27HC), an enzymatic product of CYP27A1, reduced cellular cholesterol content in prostate cancer cell lines by inhibiting the activation of sterol regulatory-element binding protein 2 and downregulating low-density lipoprotein receptor expression. Our findings suggest that CYP27A1 is a critical cellular cholesterol sensor in prostate cells and that dysregulation of the CYP27A1/27HC axis contributes significantly to prostate cancer pathogenesis.

UR - http://www.scopus.com/inward/record.url?scp=85016703269&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85016703269&partnerID=8YFLogxK

U2 - 10.1158/0008-5472.CAN-16-2738

DO - 10.1158/0008-5472.CAN-16-2738

M3 - Article

C2 - 28130224

AN - SCOPUS:85016703269

VL - 77

SP - 1662

EP - 1673

JO - Cancer Research

JF - Cancer Research

SN - 0008-5472

IS - 7

ER -